Predictors of continuation for asenapine from real-world data in patients with schizophrenia.

MLA

Takekita, Yoshiteru, et al. “Predictors of Continuation for Asenapine from Real-World Data in Patients with Schizophrenia.” Annals of General Psychiatry, vol. 23, no. 1, Aug. 2024, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s12991-024-00512-2.

APA

Takekita, Y., Hiraoka, S., Iwama, Y., Matsui, D., Aoki, N., Ogata, H., Funatsuki, T., Shimizu, T., Murase, Y., Shimamoto, Y., Koshikawa, Y., & Kato, M. (2024). Predictors of continuation for asenapine from real-world data in patients with schizophrenia. Annals of General Psychiatry, 23(1), 1–8. https://doi.org/10.1186/s12991-024-00512-2

Chicago

Takekita, Yoshiteru, Shuichi Hiraoka, Yasuhiro Iwama, Daisuke Matsui, Nobuatsu Aoki, Haruhiko Ogata, Toshiya Funatsuki, et al. 2024. “Predictors of Continuation for Asenapine from Real-World Data in Patients with Schizophrenia.” Annals of General Psychiatry 23 (1): 1–8. doi:10.1186/s12991-024-00512-2.